The firm posted 2 percent overall revenue growth as strength in Europe and the Americas was offset by softness in China and the rest of Asia.

Diagnostics' products, including its in-development point-of-care molecular diagnostics system, in Saudi Arabia and 18 other MENA countries.

The firm posted 2 percent overall revenue growth as strength in Europe and the Americas was offset by softness in China and the rest of Asia.

The firm posted 2 percent overall revenue growth as strength in Europe and the Americas was offset by softness in China and the rest of Asia.

For the third quarter Roche's diagnostics division revenues dropped 5 percent year over year led by a decline in near-patient care revenues.

NEW YORK – Having recently closed a pre-seed funding round, cancer diagnostics firm Procyon is targeting early 2026 for the UK launch of its urine-based test for early detection of pancreatic cancer.

Siemens Healthineers will leverage its regional network and healthcare technology expertise to support the adoption of Aiforia's pathology tools.

Analysts and industry watchers forecast a short-term focus on the Breast Health business and increased flexibility for long-term investments.

The firm hopes to exploit its first-mover advantage in the OTC space following de novo clearance for an at-home PCR test to detect sexually transmitted infections.

The company plans to conduct a three-year study of Parkinson's risk among people with essential tremor, using its Syn-One Test.

The deal involves the installation of 24 of Diasorin's Liaison Plex instruments at Quest labs and the supply of respiratory panel tests during flu season.